The Effects of Gyngerlean Supplementation on Energy Expenditure
The Acute Metabolic Impacts of Kaempferia Parviflora Extract in Healthy Men: a Randomized Double Blind Proof of Concept Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this randomized controlled study is to asses the effects of a ginger containing supplement on energy expenditure and substrate utilization in healthy men. The main questions it aims to answer are"
- The effects of Kaempferia parviflora extract on energy expenditure
- The effects of Kaempferia parviflora extract on substrate utilization
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2024
CompletedFirst Submitted
Initial submission to the registry
January 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedFebruary 3, 2025
January 1, 2025
16 days
January 21, 2025
January 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Resting Metabolic rate
The amount of energy/calories the body needs to function while at rest.
180 minutes
Secondary Outcomes (1)
Respiratory quotient
180 minutes
Study Arms (2)
Supplement 1
EXPERIMENTALGyngerLean™ 100 mg
Supplement 2
EXPERIMENTALGyngerLean™ 200 mg
Interventions
Alpinia galangal (Red Ginger), Kaempferia parviflora (Black Ginger), and Zingiber officinale (Yellow Ginger).
Eligibility Criteria
You may qualify if:
- Active adults. Active is defined as exercising 3 or more times a week for 30 minutes.
You may not qualify if:
- Participants must not be diabetics, have Celiac disease, or individuals with pre-existing heart or kidney disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nova Southeastern University
Davie, Florida, 333328, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Lia Jiannine
ljiannine@nova.edu
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- co-investigator
Study Record Dates
First Submitted
January 21, 2025
First Posted
February 3, 2025
Study Start
July 23, 2024
Primary Completion
August 8, 2024
Study Completion
August 8, 2024
Last Updated
February 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share